Characterization of a Pseudomonas aeruginosa efflux pump contributing to aminoglycoside impermeability

被引:178
作者
Westbrock-Wadman, S [1 ]
Sherman, DR [1 ]
Hickey, MJ [1 ]
Coulter, SN [1 ]
Zhu, YQ [1 ]
Warrener, P [1 ]
Nguyen, LY [1 ]
Shawar, RM [1 ]
Folger, KR [1 ]
Stover, CK [1 ]
机构
[1] PathoGenesis Corp, Seattle, WA 98119 USA
关键词
D O I
10.1128/AAC.43.12.2975
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Pseudomonas aeruginosa can employ many distinct mechanisms of resistance to aminoglycoside antibiotics; however, in cystic fibrosis patients, more than 90% of aminoglycoside-resistant P, aeruginosa isolates are of the impermeability phenotype, The precise molecular mechanisms that produce aminoglycoside impermeability-type resistance are yet to be elucidated. A subtractive hybridization technique was used to reveal gene expression differences between PAO1 and isogenic, spontaneous aminoglycoside-resistant mutants of the impermeability phenotype, Among the many genes found to be up-regulated in these laboratory mutants were the amrAB genes encoding a recently discovered efflux system. The amrAB genes appear to be the same as the recently described mexXY genes; however, the resistance profile that we see in P, aeruginosa is very different from that described for Escherichia coli with mexXY Direct evidence for AmrAB involvement in aminoglycoside resistance was provided by the deletion of amrB in the PAO1-derived laboratory mutant, which resulted in the restoration of aminoglycoside sensitivity to a level nearly identical to that of the parent strain. Furthermore, transcription of the amrAB genes was shown to be up-regulated in P, aeruginosa clinical isolates displaying the impermeability phenotype compared to a genotypically matched sensitive clinical isolate from the same patient. This suggests the possibility that AmrAB-mediated efflux is a clinically relevant mechanism of aminoglycoside resistance. Although it is unlikely that hyperexpression of AmrAB is the sole mechanism conferring the impermeability phenotype, we believe that the Amr efflux system can contribute to a complex interaction of molecular events resulting in the aminoglycoside impermeability-type resistance phenotype.
引用
收藏
页码:2975 / 2983
页数:9
相关论文
共 50 条
[1]  
AIRES JR, 1998, MEXGH NEW MULTIDRUG
[2]   Gapped BLAST and PSI-BLAST: a new generation of protein database search programs [J].
Altschul, SF ;
Madden, TL ;
Schaffer, AA ;
Zhang, JH ;
Zhang, Z ;
Miller, W ;
Lipman, DJ .
NUCLEIC ACIDS RESEARCH, 1997, 25 (17) :3389-3402
[3]   LIPOPOLYSACCHARIDE CHANGES IN IMPERMEABILITY-TYPE AMINOGLYCOSIDE RESISTANCE IN PSEUDOMONAS-AERUGINOSA [J].
BRYAN, LE ;
OHARA, K ;
WONG, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (02) :250-255
[4]   GENTAMICIN RESISTANCE IN CLINICAL-ISOLATES OF PSEUDOMONAS-AERUGINOSA ASSOCIATED WITH DIMINISHED GENTAMICIN ACCUMULATION AND NO DETECTABLE ENZYMATIC MODIFICATION [J].
BRYAN, LE ;
HARAPHONGSE, R ;
VANDENELZEN, HM .
JOURNAL OF ANTIBIOTICS, 1976, 29 (07) :743-753
[5]   AMINOGLYCOSIDE-RESISTANT MUTATION OF PSEUDOMONAS-AERUGINOSA DEFECTIVE IN CYTOCHROME-C552 AND NITRATE REDUCTASE [J].
BRYAN, LE ;
NICAS, T ;
HOLLOWAY, BW ;
CROWTHER, C .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 17 (01) :71-79
[6]   AMINOGLYCOSIDE-RESISTANT MUTANTS OF PSEUDOMONAS-AERUGINOSA DEFICIENT IN CYTOCHROME-D, NITRITE REDUCTASE, AND AEROBIC TRANSPORT [J].
BRYAN, LE ;
KWAN, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1981, 19 (06) :958-964
[7]   PSEUDOMONAS-AERUGINOSA CORNEAL ULCER ISOLATES DISTINGUISHED USING THE ARBITRARILY PRIMED PCR DNA-FINGERPRINTING METHOD [J].
BUKANOV, N ;
RAVI, VN ;
MILLER, D ;
SRIVASTAVA, K ;
BERG, DE .
CURRENT EYE RESEARCH, 1994, 13 (11) :783-790
[8]   GENE DISRUPTION IN ESCHERICHIA-COLI - TCR AND KM(R) CASSETTES WITH THE OPTION OF FLP-CATALYZED EXCISION OF THE ANTIBIOTIC-RESISTANCE DETERMINANT [J].
CHEREPANOV, PP ;
WACKERNAGEL, W .
GENE, 1995, 158 (01) :9-14
[9]   Electroporation of freshly plated Escherichia coli and Pseudomonas aeruginosa cells [J].
Enderle, PJ ;
Farwell, MA .
BIOTECHNIQUES, 1998, 25 (06) :954-+
[10]   The MexA-MexB-OprM multidrug efflux system of Pseudomonas aeruginosa is growth-phase regulated [J].
Evans, K ;
Poole, K .
FEMS MICROBIOLOGY LETTERS, 1999, 173 (01) :35-39